Filling a large gap in the literature, this book focuses on the management of patients who have, or are at risk of developing, cardiovascular disease. Designed to serve as a resource for the busy, practicing clinician, the approach is evidence-based but practical. Conceptual development and the exploration of biochemical and physiological mechanism

Risk Factors for Cardiovascular Disease and the Framingham Study Equation, Arterial Hypertension, Obesity and Lifestyle Modification, Effects of Nutrient Supplements and Nutraceuticals on Risk for Cardiovascular Disease, Type 1 Diabetes Mellitus, Type 2 Diabetes, Management of Elevated Low-Density Lipoprotein Cholesterol. High-Density Lipoprotein Cholesterol, Triglycerides and Risk for Atherosclerotic Disease, Safety of Dyslipidemic Agents, The Metabolic Syndrome: Identification and Management of the Patient at High Risk for Cardiovascular Disease, Inflammatory Mediators and C-Reactive Protein, Chronic Kidney Disease, Anticoagulation and Antiplatelet Agents, Congestive Heart Failure: Epidemiology, Pathophysiology, and Current Therapies, Stroke Prevention, Peripheral Arterial Disease, Acute Myocardial Infarction, Tobacco and Cardiovascular Disease, Women and Coronary Heart Disease, Cardiovascular Disease in Racial and Ethnic Minorities